The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Hyperlipoproteinemia Type IV

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hyperlipoproteinemia Type IV


High impact information on Hyperlipoproteinemia Type IV


Chemical compound and disease context of Hyperlipoproteinemia Type IV


Biological context of Hyperlipoproteinemia Type IV


Anatomical context of Hyperlipoproteinemia Type IV


Gene context of Hyperlipoproteinemia Type IV


Analytical, diagnostic and therapeutic context of Hyperlipoproteinemia Type IV


  1. Potentiation of hypoglycemic effect of sulfonylureas by halofenate. Jain, A.K., Ryan, J.R., McMahon, F.G. N. Engl. J. Med. (1975) [Pubmed]
  2. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Angelin, B., Hershon, K.S., Brunzell, J.D. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  3. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia. Maruhama, Y., Abe, R., Okuguchi, F., Oikawa, S., Ohneda, A., Goto, Y. Diabetes (1978) [Pubmed]
  4. Effects of glyburide therapy on lipoproteins in non-insulin-dependent diabetes mellitus. Hughes, T.A., Kramer, J.O., Segrest, J.P. Am. J. Med. (1985) [Pubmed]
  5. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. Brunzell, J.D., Albers, J.J., Chait, A., Grundy, S.M., Groszek, E., McDonald, G.B. J. Lipid Res. (1983) [Pubmed]
  6. Normalization on triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density-lipoprotein cholesterol. Witztum, J.L., Dillingham, M.A., Giese, W., Bateman, J., Diekman, C., Blaufuss, E.K., Weidman, S., Schonfeld, G. N. Engl. J. Med. (1980) [Pubmed]
  7. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. Wilson, D.E., Emi, M., Iverius, P.H., Hata, A., Wu, L.L., Hillas, E., Williams, R.R., Lalouel, J.M. J. Clin. Invest. (1990) [Pubmed]
  8. Does familial hypertriglyceridemia predispose to NIDDM? Sane, T., Taskinen, M.R. Diabetes Care (1993) [Pubmed]
  9. One-year trials with halofenate, clofibrate, and placebo. Dujovne, C.A., Azarnoff, D.L., Huffman, D.H., Pentikäinen, P., Hurwitz, A., Shoeman, D.W. Clin. Pharmacol. Ther. (1976) [Pubmed]
  10. Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemia. Bielmann, P., Brun, D., Moorjani, S., Gagné, C., Lupien, P., Tétreault, L. Clin. Pharmacol. Ther. (1975) [Pubmed]
  11. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Guarnieri, G.F., Ranieri, F., Toigo, G., Vasile, A., Ciman, M., Rizzoli, V., Moracchiello, M., Campanacci, L. Am. J. Clin. Nutr. (1980) [Pubmed]
  12. Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia. Podda, M., Zuin, M. Atherosclerosis (1985) [Pubmed]
  13. Influence of genetic hyperlipemia in the Zucker rat upon the lipemic response to graded estradiol exposure. Wilson, J.N., Wilson, S.P., Eaton, R.P. Atherosclerosis (1982) [Pubmed]
  14. Plasma triglyceride lowering by exercise despite increased food intake in patients with type IV hyperlipoproteinemia. Gyntelberg, F., Brennan, R., Holloszy, J.O., Schonfeld, G., Rennie, M.J., Weidman, S.W. Am. J. Clin. Nutr. (1977) [Pubmed]
  15. Type IV hyperlipoproteinemia: effects of a caloric restricted type IV diet versus physical training plus isocaloric type IV diet. Lampman, R.M., Santinga, J.T., Bassett, D.R., Block, W.D., Mercer, N., Hook, D.A., Flora, J.D., Foss, M.L. Am. J. Clin. Nutr. (1980) [Pubmed]
  16. Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size. Angelin, B., Bjökhem, I., Einarsson, K. J. Lipid Res. (1978) [Pubmed]
  17. Triglyceride accumulation in cultured human fibroblasts: the effects of hypertriglyceridemic serum. Howard, B.V., Howard, W.J., De la Llera, M., Kefalides, N.A. Atherosclerosis (1976) [Pubmed]
  18. Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Shoji, T., Nishizawa, Y., Nishitani, H., Yamakawa, M., Morii, H. Metab. Clin. Exp. (1991) [Pubmed]
  19. Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. Whitman, S.C., Sawyez, C.G., Miller, D.B., Wolfe, B.M., Huff, M.W. J. Lipid Res. (1998) [Pubmed]
  20. Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Love, M.W., Craddock, A.L., Angelin, B., Brunzell, J.D., Duane, W.C., Dawson, P.A. Arterioscler. Thromb. Vasc. Biol. (2001) [Pubmed]
  21. No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes. Heliö, T., Palotie, A., Sane, T., Tikkanen, M.J., Kontula, K. Hum. Genet. (1994) [Pubmed]
  22. Platelet function in patients with familial hypertriglyceridemia: evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles. Pedreño, J., Hurt-Camejo, E., Wiklund, O., Badimón, L., Masana, L. Metab. Clin. Exp. (2000) [Pubmed]
  23. Type IV hyperlipoproteinemia and moderate instability of CAG triplet expansion in the androgen-receptor gene. Lipid, sex hormone and molecular study in a Chinese family with Kennedy-Alter-Sung disease. Liu, C.S., Chang, Y.C., Chen, D.F., Huang, C.C., Pang, C.Y., Lee, H.C., Cheng, C.C., Horng, C.J., Wei, Y.H. Acta neurologica Scandinavica. (1995) [Pubmed]
  24. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia. Saku, K., Gartside, P.S., Hynd, B.A., Mendoza, S.G., Kashyap, M.L. Metab. Clin. Exp. (1985) [Pubmed]
  25. Gas-liquid chromatography profiling of intact lipids. Observation of differences between triglyceride structure of lipoproteins in type III and type IV hyperlipoproteinemia. Skorepa, J., Kahudová, V., Kotrlíková, E., Mares, P., Todorovicová, H. J. Chromatogr. (1983) [Pubmed]
  26. Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia. Otto, C., Pschierer, V., Soennichsen, A.C., Schwandt, P., Richter, W.O. Metab. Clin. Exp. (1997) [Pubmed]
  27. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. Glueck, C.J., Lang, J., Hamer, T., Tracy, T. J. Lab. Clin. Med. (1994) [Pubmed]
WikiGenes - Universities